Improvement in fibrosis 1 stage without worsening of NASH was achieved in 26% with 30 mg and in 27% with 44 mg, versus 7% with placebo (p = 0.009 and p = 0.008), and resolution of NASH without worsening of fibrosis in 23% with 30 mg, 26% with 44 mg, and 37% with 15 mg, versus 2% with placebo
Semaglutide in managing fibromyalgia pain: Mechanisms and clinical outcomes
Confirm the concentration
Other conditions that can cause issues with fat absorption include Crohns disease, pancreatitis, liver disease, exocrine pancreatic insufficiency (EPI), or cancers of the pancreas, liver, or bile duct
Semaglutide ameliorates Alzheimer's disease and restores oxytocin in APP/PS1 mice and human brain organoid models, Biomedicine & Pharmacotherapy (2024), DOI - 10.1016/j.biopha.2024.117540,
Scientific References Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction